A simple method of simultaneous analysis for chloramphenicol and chioramphenicol succinate in 10-L samples of plasma is described. We injected the plasma samples directly into a radial-compression liquid chromatograph equipped with a precolumn module and a C18 insert. A mixture of acetic acid solution (pH 3)/acetonitrile (75/25, by vol) was used as mobile phase, at a flow rate of 4 mL/min. We separated the compounds in a 10-j.m (particle size) C15 cartridge with a radial compression separation system and detected them in the effluent at 280 nm. The peak height for both compounds was linearly (r >0.9993) related to concentration over the range investigated, 1-50 mg/L. We also performed the analysis with use of an internal standard (methyiprednisolone) and obtained equally good results (r >0.9995). We observed no interference from other antibiotics or drugs in the assay, and the inter-and intra-run precision at different concentrations was good (CV, 0 to 5.6%). We analyzed microsamples of plasma from an infant treated for meningitis with chloramphenicol sodium succinate intravenously. Total analysis time for each sample was <8 mm.
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AddItional Keyphrases: drug monitoring . pediatric chemistry meningitis
Chloramphenicol is a potent antibiotic, with a wide spectrum of activity against several microorganisms, including E. typhosa, E. coli, Brucelkz, and H. influenzae. It is the drug of choicefortreatment of typhoidand paratyphoid fevers and, in pediatrics,for meningitis, fulminating respiratory infections, and septicemias caused by H. influenzae type b. This drug, however, is associated with severe hematopoietic toxicity-e.g., thrombocytopenia, granulocytopenia, and aplastic anemia-as well as the "grey baby" syndrome (1). Because ofcloseassociations between toxicity or efficacy and the concentration of this drug in plasma, the need to monitor this drug in plasma has been repeatedly emphasized (2) (3) (4) (5) (6) . Chloramphenicol monosuccinate salt is highly water-soluble and therefore is used intravenously as the prodrug for chloramphenicol. However, shortly after intravenous administration both chloramphenicol and its monosuccinate ester are found in biological fluids and hence need to be simultaneously analyzed.
Of all the techniques used for simultaneous analysis of chloramphenicol and chloramphenicol succinate in blood, radial-compression liquid chromatography has not been previously reported. Furthermore, most of the currently available methods require 0.1-0.5 mL of plasma or serum (7) (8) (9) (10) (11) (12) small volume makes direct injection economically feasible with a cartridge life span essentially unaltered. The absence of an extraction step in this assay and the rapidity and efficiency of radial-compression liquid chromatography shorten the total analysis to less than 8 mm for both compounds, a time unmatched by previous assays.
Materials and Methods

Reagents
The phosphoric acid (85%) and acetonitrile (Fisher Scientific Co., Fair Lawn, NJ) we used in preparing the mobile phase were "HPLC" grade. We prepared water for chromatography by passing de-ionized water through a NorganictM cartridge to remove trace amounts of organic compounds and a 45-sm (pore-size) membrane filter (both from Millipore Co., Milford, MA). Chioramphenicol precolumn module with a C18 insert, a radialcompression separation module (Z-Module) equipped with a 10-sm-particle-packed, 8 mm x 10 cm C15 Radial PakT cartridge, a variable-wavelength ultraviolet detector (Model 480), and a data module (Model 730). We set the detectorat 280 nm, the absorption maximum for chloramphenicol.
Procedures
Mobile phase. We prepared the mobile phase by mixing 750 mL of an aqueous solution of acetic acid (pH 3) with 250 mL of acetonitrile, and filtering and degassing the mixture before use. A flow rate of 4 mL/min at a pressure of 6.88 MPa (1000 psi)was used.
Standard curves. To compute the concentration of chloramphenicol or chloramphenicol succinate in the unknown samples, we constructed standard curves in the range 1-50 g/mL. Portions of blank plasma were supplemented with 50 g of each of the abovu drugs per milliliter, and the resulting samples were appropriately diluted with blank plasma toyieldthe followingconcentrations:25, 20, 10,7,5, 2, and 1 jg/mL. We then transferred the samples to autosampler microvials, and programmed the autosampler to inject 10 L from each microvial in duplicate.
To examine whether the use of internal standard affects the results under the described conditions, we similarly constructed another set of standard curves, but added to each sample an equal volume of 400 ig/mL methylprednisolone (internal standard) solution in methanol/water (20/80 by vol).The autosampler was programmed to inject 20 L of each sample in duplicate. We investigated the applicability of the assay by analyzing plasma samples obtained from a six-month-old female patient(weight4 kg) who was being treated for meningitis with an intravenous dose of chloramphenicol sodium succinate equivalent to 75 mg of chloramphenicol every 6 h. The samples were collected immediately before (Sample 1) and after (Sample 2) administration of the first dose on the fourth day of therapy. The analysis was performed with and without the use of the internal standard. When no internal standard was added, we computed the concentrations by using a peak-height vs concentration standard curve or a single "standard" plasma sample to which known amounts of chioramphenicol and chioramphenicol succinate were added. Figure   1 illustrates typical chromatograms for blank plasma, blank plasma supplemented with chloramphenicol, and a plasma sample collected from the above-mentioned six-month-old patient. Figure 2 depictsa chromatogram of drug-free sample of plasma to which chloramphenicol, chloramphenicol succinate, and methylprednisolone (internal standard)
Results and Discussion
were added. As shown in these figures, the chromatograms are "clean," even though the samples were untreated and were directly injected into the cartridge. Also, the peaks were symmetrical, with retentiontimes forchloramphenicol and methylprednisolone of 3.4 and 9.8 mm, respectively. There were two fullyresolved peaks for chioramphenicol succinate with retention times of 4.7 (II) and 6.3 miii (ifi) and an area ratio (Il/ifi) of 1:3.94, respectively. This is in agreement with the 20:80 ratio reported earlier TIME ,min peak (H) represents the cyclic hemi-ortho monosuccinate ester of chloramphenicol and the second (ifi) represents the non-cyclic form of this compound (13, 14) . We examined the linearity of the assay by constructing, on different days, standard curves in the range 1-50 g/mL. The peak height varied highly linearly with concentration:
correlationcoefficients (r) forchioramphenicol ranged from 0.9993 to 0.9999 (mean = 0.9996; CV = 0.02%; n = 10).For chloramphenicol succinate, r ranged from 0.9993 to 0.99995 (mean = 0.9996;CV = 0.025%; n = 5).The use of an internal standard (methyiprednisolone) did not improve the results for either drug: for chloramphenicol, the correlation coefficient for the standard curves representing peak-height (drug/internal standard) ratio vs concentration ranged from 0.9992 to 0.9998 (mean = 0.9995; CV = 0.024%; n = 5), and for chloramphenicol succinate r ranged from 0.9997 to 0.9999 (mean = 0.9998; CV = 0.0091%; n 5). Similarly, the use of the internal standard did not significantly affect the estimates of the concentrations of the two compounds in the patient's samples analyzed (Table 1) . This is not surprising, because the sample was not subjected to error-prone extraction procedures and the autoinjector is exceedingly precise (CV = 1%). We also computed the concentrations in the patient's samples by use of a single "standard" plasma sample supplemented with 20 mg of chloramphenicol and 10 mg of chloramphenicol succinate per liter. As Table 1 shows, the concentrations obtained with this approachdidnotdiffer significantly from those obtained by use of standard curves where internal standard was or was not used. Evidently, with this assay no internal standard isneeded (although itsuse isrecommended on principle)and the concentration can be reliablycalculatedby use ofa single"standard"sample, which shortens the analysis.
As shown in Table 2 , the analytical recoveryofchloramphenicol in concentrations of 1, 2, 5, 7, 10, 15, 20, 25 , and 50 mg/L was 94-105%. The intra-run precision of the assay was equally good: at no concentration did the CV exceed 4.2% (Table2).We determined these parameters by analyzing six to eight samples at each concentration. Inter-run precision was also good: CVs for the concentrations of both compounds in the patient's samples ranged from 1.4 to 5.6% (Table 1) .
To investigate the specificity of the assay, we determined the retention times of drugs that may concomitantly be used withchioramphenicol (Table3).No interference in the assay was observed, althoughthe analystshouldof course be alert forother drugs that could interfere.
The smallest concentration we analyzed under the described conditions was 1 mg/L; however, by changing the attenuation of the detector to 0.01 A full scale the peak that corresponds to 0.5 mg/L can easily be measured and quantified. If the "front" plasma peak is not fully resolved from that for chloramphenicol, a complete resolution can be achieved by increasing the proportion of acetic acid in the mobile phase to 80%.
In conclusion, we present here a simple, direct assay for simultaneous analysisof chloramphenicoland chloramphenicol succinate in plasma. Because of the ease (no extraction), rapidity (total analysis time = 8 mm), and limited sample volume (10 p.L) required, this assay is especially suitable for therapeutic monitoring of drugs in patients, particularly pediatric patients.
